BEACHBODY CO INC/THE (BODY) Forecast, Price Target & Analyst Ratings
NYSE:BODY • US0734633094
8.14 USD
-0.17 (-2.05%)
Last: Mar 1, 2024, 08:04 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BEACHBODY CO INC/THE (BODY).
Forecast Snapshot
Consensus Price Target
$28.05
+ 244.59% Upside
Next Earnings Forecast
Release DateMar 12, 2024
PeriodQ4 / 2023
EPS Estimate-$3.19
Revenue Estimate110.93M
ChartMill Buy Consensus
80.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$28.05
Upside
+ 244.59%
From current price of $8.14 to mean target of $28.05, Based on 9 analyst forecasts
Low
$12.63
Median
$15.30
High
$57.75
Price Target Revisions
1 Month
0.00%
3 Months
-42.11%
Price Target Summary
9 Wall Street analysts provided a forecast for the next 12 months for BODY. The average price target is 28.05 USD. This implies a price increase of 244.59% is expected in the next year compared to the current price of 8.14.
The average price target has been revised downward by 42.11% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
BODY was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about BODY.
In the previous month the buy percentage consensus was at a similar level.
BODY was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-01-05 | Roth MKM | Initiate | Buy |
| 2023-05-31 | DA Davidson | Maintains | Buy -> Buy |
| 2023-03-16 | Baird | Maintains | Neutral |
| 2023-03-15 | Credit Suisse | Maintains | Neutral |
| 2022-11-10 | Credit Suisse | Maintains | Neutral |
| 2022-08-09 | DA Davidson | Maintains | Buy |
| 2022-05-17 | DA Davidson | Maintains | Buy |
| 2022-05-10 | Credit Suisse | Maintains | Neutral |
| 2022-05-05 | Credit Suisse | Initiate | Neutral |
| 2022-03-04 | DA Davidson | Maintains | Buy |
| 2021-11-17 | Loop Capital | Downgrade | Hold -> Sell |
| 2021-11-16 | Guggenheim | Downgrade | Buy -> Neutral |
| 2021-11-16 | Baird | Downgrade | Outperform -> Neutral |
| 2021-10-06 | Cantor Fitzgerald | Initiate | Neutral |
| 2021-08-16 | DA Davidson | Maintains | Buy |
| 2021-07-27 | Guggenheim | Initiate | Buy |
| 2021-07-09 | Baird | Initiate | Outperform |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 12, 2024
PeriodQ4 / 2023
EPS Estimate-$3.19
Revenue Estimate110.93M
Revenue Q2Q-25.15%
EPS Q2Q57.50%
Number of Analysts5
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
3.48%
EPS (1 Month)
0.00%
EPS (3 Months)
21.88%
Next Earnings Summary
BODY is expected to report earnings on 3/12/2024. The consensus EPS estimate for the next earnings is -3.19 USD and the consensus revenue estimate is 110.93M USD.
The next earnings revenue estimate has been revised upward by 3.48% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 863.6M 14.26% | 873.6M 1.16% | 692.2M -20.76% | 527.19M -23.84% | 497.35M -5.66% | 504.59M 1.46% | |
| EBITDA YoY % growth | 43.75M -40.44% | -125.26M -386.31% | -74.07M 40.87% | -12.75M 82.79% | 17.34M 236.00% | 26.52M 52.94% | |
| EBIT YoY % growth | -8M -139.41% | -199.7M -2,396.25% | -173.2M 13.27% | -96.594M 44.23% | -35.7M 63.04% | -26.52M 25.71% | |
| Operating Margin | -0.93% | -22.86% | -25.02% | -18.32% | -7.18% | -5.26% | |
| EPS YoY % growth | N/A | N/A | -13.38 48.36% | -17.17 -28.34% | -5.95 65.37% | -4.55 23.50% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -3.19 57.50% | -2.13 52.63% | -1.31 67.36% | -1.42 74.22% | -1.10 65.44% | -0.05 97.61% | -0.05 96.09% | -0.05 96.40% | -0.05 95.37% |
| Revenue Q2Q % growth | 110.93M -25.15% | 134.03M -7.50% | 125.56M -6.92% | 125.77M -1.97% | 112M 0.96% | 145.86M 8.83% | 148.16M 18.00% | 150.47M 19.64% | 152.84M 36.46% |
| EBITDA Q2Q % growth | -1.02M -101.46% | 100.00% | 5.61M -32.81% | 4.794M -76.14% | 6.936M 780.00% | 4.733M | 4.804M -14.37% | 4.876M 1.71% | 4.957M -28.53% |
| EBIT Q2Q % growth | -14.28M 51.10% | -13.26M 39.73% | -7.65M 68.52% | -8.466M 69.55% | -6.324M 55.71% | -13.27M -0.08% | -13.484M -76.27% | -13.688M -61.69% | -13.913M -120.00% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
18.40%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-10.52%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
29.04%
EBIT Next 5 Year
N/A
BEACHBODY CO INC/THE / BODY Forecast FAQ
What do analysts expect the price target to be for BEACHBODY CO INC/THE (BODY)?
9 analysts have analysed BODY and the average price target is 28.05 USD. This implies a price increase of 244.59% is expected in the next year compared to the current price of 8.14.
Can you provide the upcoming earnings date for BEACHBODY CO INC/THE?
BEACHBODY CO INC/THE (BODY) will report earnings on 2024-03-12, after the market close.
What are the consensus estimates for BEACHBODY CO INC/THE (BODY) next earnings?
The consensus EPS estimate for the next earnings of BEACHBODY CO INC/THE (BODY) is -3.19 USD and the consensus revenue estimate is 110.93M USD.
What is the number of analysts for BODY stock?
The number of analysts covering BEACHBODY CO INC/THE (BODY) is 9.